On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
On Sept. 30, 2025, a team of engineers at the University of Massachusetts Amherst announced the creation of…
On Sept. 25, 2025, the National Institutes of Health (NIH) announced the award of contracts for launching the…
On Sept. 25, 2025, The California Institute for Regenerative Medicine (CIRM) has approved awarding more than $73 million…
On Sept. 24, 2025, a global clinical trial for a new Huntington’s disease treatment has posted positive results,…
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA) announced it had initiated the approval of…
On Sept. 20, 2025, scientists from around the world gathered at a conference in Shanghai to launch the…
On Sept. 18, 2025, Biogen announced it has has entered into a definitive agreement to acquire Massachusetts-based Alcyone…
On Sept. 14, 2025, scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University…
On Sept. 10, 2025, a major University of London (UCL)-led clinical trial, aiming to transform the diagnosis of…
On Sept. 3, 2025, The International Brain Laboratory (IBL) researchers published their findings today in two papers in Nature, revealing…
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
On Sept. 2, 2025, Arrowhead Pharmaceuticals announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s…
On Aug. 27, 2025, a new fun created by Allen’s estate under the late Microsoft co-founder’s instructions, was…
On Aug. 25, 2025, AbbVie and Gilgamesh Pharmaceuticals announced a definitive agreement under which AbbVie will acquire Gilgamesh’s…
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
On Aug. 18, 2025, Skyhawk Therapeutics announces a strategic research collaboration with Merck KGaA, Darmstadt, Germany. The collaboration…
On Aug. 7, 2025, The National Institute for Health and Care Excellence (NICE) has today announced the approval…
On Aug. 6, 2025, Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone)…
On Aug. 1, 2025, Tissium announced it has begun offering surgeons a new solution based on a biopolymer…
On Jul. 29, 2025, Texas A&M study finds immersive VR nature experiences improve mood and quality of life….
On Jul. 28, 2025, a study published in Nature Neuroscience shows that potential contact with approaching infectious avatars,…
On Jul. 28, 2025, Kaiser Permanente Washington Health Research Institute (KPWHRI) and Kaiser Permanente Center for Health Research…
On Jul. 24, 2025, an analysis of studies incorporating data from almost 30 million people has highlighted the…
On Jul. 23, 2025, research at Tufts and elsewhere has revealed the eight essential nutrients that make up…
On Jul. 22, 2025, Health officials have confirmed a case of brain-eating amoeba in South Carolina. The state’s…
On Jul. 21, 2025, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing…
On Jul. 18, 2025, The Environmental Protection Agency (EPA) said it is eliminating its research and development arm…